
Scan other defense and EMS testing opportunities by shortlisting companies exposed to similar demand trends through our curated 42 power grid technology and infrastructure stocks
To stay invested in Viavi Solutions, you need to believe the test and measurement portfolio can absorb telecom cyclicality through steadier demand from data centers, fiber build outs, and now defense and aerospace. The T/Rx win with the U.S. Army fits that thesis as another proof point that Viavi’s technology is relevant in high value, mission critical applications beyond traditional carriers.
In the near term, the key swing factor is whether data center and fiber spending keep offsetting weak wireless infrastructure test activity and lumpy service provider budgets. The biggest risk still sits in integration and execution on acquisitions plus higher debt, rather than this single T/Rx award, which looks helpful but not business defining on its own.
The recent selection of Viavi’s T/Rx system for the Army’s Test Range Private Industry Initiative is the clearest link to the defense diversification catalyst already in the story. It shows Viavi equipment being embedded in test infrastructure that commercial drone and counter drone developers are expected to use, which can deepen relationships in aerospace and defense over time.
For you as an investor, that ties back to the goal of reducing reliance on cyclical service provider and cable spending while adding customers that view rigorous EMS testing as non discretionary. The operational question now is execution: whether Viavi can scale similar deployments across multiple ranges and programs while managing supply chain exposure, integration tasks, and the higher financing load on the balance sheet.
Viavi Solutions' current analyst narrative points to US$2.5b in revenue and US$503.0m in earnings by 2029, built on assumed 18.0% yearly revenue growth and a swing in profitability from an earnings loss of US$30.4m today to that US$503.0m figure. This implies an earnings increase of about US$533.4m from the current base.
Uncover why Viavi Solutions' fair value indicates a 93% potential upside to its current price before the market closes that gap.
You also need to weigh a different angle. The most bearish analysts worry that Viavi Solutions is leaning too hard on AI driven data centers, even while they still penciled in about US$2.5b of 2029 revenue and roughly US$524.5m in earnings before this Army T/Rx news. That gap in expectations shows how widely views can spread, so it is worth comparing several narratives yourself and deciding which one feels more realistic if contracts like this keep emerging.
Explore 3 other Viavi Solutions fair value estimates, including one that suggests as much as 11% downside from the current price.
Don't just follow the ticker, dig into the data and build a conviction that's truly your own.
If the Viavi Solutions story has you thinking about how to balance risk, income, and quality across your portfolio, it can help to line it up against other stocks facing different demand drivers. The Simply Wall St Screener lets you filter for the kind of businesses that match your priorities, whether you care more about resilience, income today, or upside potential over time.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com